DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+3.14%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.82B
AUM Growth
+$2.82B
(+11%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
5.92%
Top 10 Holdings %
Top 10 Hldgs %
31.06%
Holding
130
New
28
Increased
28
Reduced
22
Closed
14
Top Buys
| 1 |
Q32 Bio
QTTB
|
$97.7M |
| 2 |
Centene
CNC
|
$62.8M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$41.3M |
| 4 |
CVS Health
CVS
|
$34.2M |
| 5 |
GSK
GSK
|
$31.6M |
Top Sells
| 1 |
DexCom
DXCM
|
$65.6M |
| 2 |
Glaukos
GKOS
|
$52.4M |
| 3 |
Insulet
PODD
|
$46.3M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$35.8M |
| 5 |
McKesson
MCK
|
$34.5M |
Sector Composition
| 1 | Healthcare | 76.69% |
| 2 | Financials | 1.51% |
